SCHEMBL7567337

SCHEMBL7567337

CCCCOC(=O)C(CC)NC(=O)Cc1ccc2ccccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 3/20 0.48
HDAC10 Q969S8 2/20 0.46
HDAC6 Q9UBN7 2/20 0.46
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
CTSD P07339 2/20 0.45
KDM4E B2RXH2 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
PDE4A P27815 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7573224 0.87 CNR2 (0.58) HDAC10HDAC6MEN1KMT2AL3MBTL1
SCHEMBL4565762 0.84 ELANE (0.54) ELANEMEN1KMT2AL3MBTL1TACR1
SCHEMBL8599743 0.83 CA2 (0.46) HDAC10HDAC6MEN1KMT2AL3MBTL1
SCHEMBL7569870 0.82 TDP1 (0.58) HDAC10HDAC6KMT2AKDM4ECYP1A2
SCHEMBL7571115 0.82 KMT2A (0.54) HDAC10HDAC6HDAC1KMT2AL3MBTL1
SCHEMBL7576943 0.82 CNR2 (0.51) HDAC10HDAC6MEN1KMT2AL3MBTL1
SCHEMBL7574286 0.82 CNR2 (0.46) HDAC10HDAC6KDM4ECYP1A2CYP2D6
SCHEMBL7571824 0.82 EPHX2 (0.51)
SCHEMBL7571045 0.82 GLS (0.45) HDAC10HDAC6KDM4ECYP1A2CYP2D6
SCHEMBL6136552 0.80 MME (0.58) ELANEMEN1KMT2AL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998022494-A9 METHODS AND COMPOUNDS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR SYNTHESIS 1998-08-20 WO disclosed